REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 2 filers reported holding REVOLUTION MEDICINES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572,727 | +627.0% | 20,691 | +602.6% | 0.02% | +500.0% |
| Q2 2023 | $78,779 | +106358.1% | 2,945 | -13.8% | 0.00% | +50.0% |
| Q1 2023 | $74 | +60.9% | 3,418 | +76.5% | 0.00% | 0.0% |
| Q4 2022 | $46 | -100.0% | 1,937 | -67.5% | 0.00% | 0.0% |
| Q3 2022 | $117,000 | -4.9% | 5,951 | -5.8% | 0.00% | -33.3% |
| Q2 2022 | $123,000 | -35.3% | 6,319 | -15.1% | 0.00% | +50.0% |
| Q1 2022 | $190,000 | +1.1% | 7,439 | -0.6% | 0.00% | -33.3% |
| Q4 2021 | $188,000 | +12.6% | 7,483 | +23.4% | 0.00% | -25.0% |
| Q3 2021 | $167,000 | +24.6% | 6,066 | +43.8% | 0.00% | +33.3% |
| Q2 2021 | $134,000 | +42.6% | 4,219 | +106.5% | 0.00% | +50.0% |
| Q1 2021 | $94,000 | -38.6% | 2,043 | -47.1% | 0.00% | -60.0% |
| Q4 2020 | $153,000 | -57.1% | 3,863 | -62.3% | 0.01% | +25.0% |
| Q3 2020 | $357,000 | +301.1% | 10,247 | +262.5% | 0.00% | 0.0% |
| Q2 2020 | $89,000 | – | 2,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $175,333,000 | 30.61% |
| TRV GP IV, LLC | 1,419,900 | $45,068,000 | 21.46% |
| Ponoi II Management, LLC | 685,011 | $21,742,000 | 17.62% |
| Column Group LLC | 3,347,245 | $106,242,000 | 15.04% |
| Ponoi Management, LLC | 685,011 | $21,742,000 | 12.08% |
| Boxer Capital, LLC | 3,484,264 | $110,591,000 | 3.90% |
| Cormorant Asset Management, LP | 3,338,166 | $105,953,000 | 3.60% |
| BVF INC/IL | 2,485,049 | $78,875,000 | 2.96% |
| Casdin Capital, LLC | 2,305,000 | $73,161,000 | 1.86% |
| Burrage Capital Management LLC | 50,000 | $1,587,000 | 1.59% |